
Indiana University is teaming with the Indiana Sports Corp. and Pacers Sports & Entertainment for what it calls a first-of-its-kind research program dedicated to the health, performance and lifelong well-being of female athletes.
The Female Sports Performance and Research Initiative, announced Tuesday, aims to broaden the focus on female athletes in performance and health research, providing women-centered data for decision-makers who often have to rely on male-dominated data sets to develop policies and protocols.
“There’s just so much energy in women’s sports, especially here in Indiana, and then in IU, we have a lot of great sports performance work. We have a great medical school. We have really strong data science and informatics,” Katie Siek, an informatics professor who is co-chairing the initiative’s research committee, told Inside INdiana Business. “With all of these systems, it’s just the opportune time for us to kind of capitalize on all of those strengths and bring it together for a really important area that’s under-studied.”
The initiative is developed in partnership with the IU Launch Accelerator for Biosciences, or IU LAB.
“We wanted to focus on the female athlete and building out that cohort and investing in that research, because we think that research can help maximize performance [and] help prevent injury. If there is an injury, getting the athlete back on the field sooner.” IU LAB President and CEO David Rosenberg told IIB. “It’s really a first-of-its-kind research program that’s dedicated to the health, the performance, the well-being of the female athlete.”
The goal is to generate data to support evidence-based guidelines for training, injury prevention, recovery and overall health promotion.
“I am a first generation college student, and I got through college playing basketball for a Division II (school) and you know, throughout my entire life, there’s just been these injuries. And when I talk to my doctors and such (they say) ‘we just don’t know … we don’t have enough data,’” Siek said. “With IU LAB, it provides that really easy interface between academia and industry.”
The Indiana Sports Corp unveiled its Vision 2050 last September with the goal of “building a landscape that can establish and maintain Indianapolis as a world capital for teams, events and organizations.” The efforts focus on five pillars of growth, one of which is women’s sports.
“Indiana is ready to lead a national movement to reimagine the female athletic experience,” Patrick Talty, president of Indiana Sports Corp, said in a written statement. “This effort is deeply rooted in our city’s commitment to sports innovation and community impact, and it aligns with our economic strategy to lead the future of sports.”
Siek says IU is also looking for partners and hopes to collaborate with several industry groups.
“With this current funding environment, we’re also looking at how we can redefine how we fund research so it could be more about making partnerships,” she said. “We envision this future where, when we have this cohort, that someone can come in and say, ‘I have this product,’ and we would have a group of people ready to use that product. There’s so much opportunity.”
The new initiative comes a week after IU announced a five-year agreement with Bloomington-based Cook Medical that will allow researchers from both organizations to collaborate and innovate. The IU LAB will serve as the coordinating organization for projects statewide.
Rosenberg was announced as the leader of IU LAB in January, about a month after IU announced the biosciences accelerator that’s being supported by a $138 million grant from Indianapolis-based Lilly Endowment Inc.
“IU LAB overall is really that front door between IU’s academics, researchers and experts and our external industry partners. We pulled together about 50 participants in May to have our first roundtable. I’ll tell you, the energy and excitement around it was awesome,” Rosenberg said. “Because of the discussion, because of the experts and assets that we have in Indiana, we knew we could really lean in and launch this first-of-a-kind research program with the Indiana Sports Corp and Pacers Sports & Entertainment.”
In 2023, IU announced a $250 million investment intended to position the university as a leader in life sciences and biotechnology innovation. In December 2024, IU received the Lilly Endowment grant to fund construction of a state-of-the-art facility for that work. A groundbreaking for that building at the 16 Tech Innovation District on Indianapolis’ west side, is scheduled for later this year and expected to open in 2027.
IIB Managing Editor Alex Brown contributed to this story.
